China Medical GatewayLoading your healthcare gateway…

Lin Guo Wen

Lin Guo Wen — Associate Chief Physician — Urology — Fudan University Affiliated Cancer Hospital

Specialties

1. Radical prostatectomy (robotic surgery, ultra-nerve-sparing minimally invasive surgery), precise prostate biopsy (referred to as 'precise puncture Lin Yi needle'), differential diagnosis of elevated PSA, prostate cryoablation, radical nephrectomy for kidney cancer, minimally invasive surgery for bladder tumors, radical surgery for penile/testicular cancer, etc. 2. Experience in complex advanced prostate cancer drug treatment. 3. Surgical treatment of metastatic prostate cancer, targeted therapy.

Education

PhD in Surgery, Fudan University Master's in Oncology, Fudan University Bachelor's in Clinical Medicine, Fudan University

Professional Experience

Associate Chief Physician of Urology, Doctor of Medicine, Associate Professor of Teaching, Master's Supervisor, Chief Expert in Prostate Biopsy at the Cancer Hospital, Member of the Prostate Expert Group at the Cancer Hospital. Visiting physician at CHUM Hospital in Canada and MD Anderson Cancer Center in the United States, review expert for the Shanghai Science and Technology Commission. Has worked at Fudan University Affiliated Cancer Hospital for nearly 20 years. Possesses extensive experience in the diagnosis and treatment of urologic tumors, focusing on prostate cancer, kidney cancer, and bladder cancer. Specializes in: 1) Radical prostatectomy for prostate cancer (robotic surgery, fluorescence system-guided prostatectomy), creating a 36-minute rapid minimally invasive radical surgery; 2) Precision prostate biopsy, with a nationwide leading positive rate in biopsy, laying the foundation for early detection and early treatment of prostate tumors; 3) Drug treatment for advanced tumors. First in China to propose PSMA imaging combined with multiparametric MRI-guided targeted prostate biopsy, chief editor of the "Chinese Expert Consensus on Prostate Biopsy" and "Expert Consensus on Perioperative Treatment of High-risk Localized Prostate Cancer." A CDFI ultrasonographer (one of the few urologists in the country with ultrasound diagnostic qualifications) and senior health management specialist. Member of the International Urological Association and Shanghai Anti-Cancer Association. Has conducted academic presentations and exchanges at major conferences such as the American Urological Association Annual Meeting (AUA), the International Urological Association Annual Meeting (SIU), MD Anderson Cancer Center Annual Meeting (GAP), National CSCO Conference, Chinese Oncology Academic Conference, and national and Shanghai Urology Annual Meetings.

Professional Roles

Member of the Urological and Male Reproductive Tumor Professional Committee of the Chinese Anti-Cancer Association, Member of the Primary Work Committee of the Chinese Society of Integrative Medicine, Member of the Oncology Intelligent Diagnosis and Treatment Professional Committee of the Chinese Society of Bioengineering, Member of the Cancer Prevention and Screening Professional Committee of the Shanghai Anti-Cancer Association, Member of the Clinical Research on Anti-Cancer Drugs Professional Committee of the Shanghai Anti-Cancer Association, Young Standing Committee Member of the Cancer Rehabilitation and Palliative Care Special Committee of the Shanghai Anti-Cancer Association, Member of the Medical Equipment Committee of the Chinese Medical Education Association

Return to Home